title: Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study.
abstract: Prior to 1990, many patients with inherited bleeding disorders were infected with hepatitis C virus (HCV). This study assessed the risk of end-stage liver disease (ESLD) in patients with hemophilia with chronic hepatitis C. Patients were infected between 1961 and 1990 and were followed up to August 2005. Of 847 anti-HCV(+) patients, 160 (19%) spontaneously cleared HCV and 687 (81%) developed chronic hepatitis C. Coinfection with HIV was present in 210 patients. After 35 years of infection the cumulative incidence of ESLD was 11.5% (95% CI, 8.2%-14.8%) in HIV(-) patients and 35.1% (95% CI, 29.2%-41.0%; P < .001) in patients coinfected with HIV. Independent risk factors of ESLD were HIV coinfection (hazard ratio 13.8; 95% CI, 7.5-25.3), older age at infection (hazard ratio 2.3 per 10 years; 95% CI, 2.0-2.8), alcohol abuse (hazard ratio 4.9; 95% CI, 2.5-9.6), and presence of HCV genotype 1 (hazard ratio 2.2; 95% CI, 1.1-4.2). With longer duration of HCV infection, the risk of developing ESLD is emerging in patients with inherited bleeding disorders. Risk factors for rapid progression to ESLD are alcohol abuse, coinfection with HIV, older age at infection, and presence of HCV genotype 1.
authors.affiliation: Van Creveldkliniek, University Medical Center Utrecht, The Netherlands.
authors.forename: Dirk
authors.initials: D
authors.lastname: Posthouwer
authors.forename: Michael
authors.initials: M
authors.lastname: Makris
authors.forename: Thynn T
authors.initials: TT
authors.lastname: Yee
authors.forename: Kathelijn
authors.initials: K
authors.lastname: Fischer
authors.forename: Joost J
authors.initials: JJ
authors.lastname: van Veen
authors.forename: Anja
authors.initials: A
authors.lastname: Griffioen
authors.forename: Karel J
authors.initials: KJ
authors.lastname: van Erpecum
authors.forename: Eveline P
authors.initials: EP
authors.lastname: Mauser-Bunschoten
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D018450:Disease Progression; D005060:Europe; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D015658:HIV Infections / Q000209:etiology / Q000235:genetics / Q000401:mortality*; D006470:Hemorrhage / Q000150:complications / Q000235:genetics / Q000401:mortality*; D006474:Hemorrhagic Disorders / Q000150:complications / Q000235:genetics / Q000401:mortality*; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000150:complications / Q000235:genetics / Q000401:mortality*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate